Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Nature's Sunshine Products, Inc is a household & personal products business based in the US. Natures Sunshine Products shares (NATR) are listed on the NASDAQ and all prices are listed in US Dollars. Natures Sunshine Products employs 834 staff and has a trailing 12-month revenue of around USD$375.2 million.
|52-week range||USD$5.5 - USD$18.16|
|50-day moving average||USD$16.6518|
|200-day moving average||USD$13.3711|
|Wall St. target price||USD$15|
|Dividend yield||USD$0 (0%)|
|Earnings per share (TTM)||USD$0.83|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Natures Sunshine Products stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Natures Sunshine Products's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Natures Sunshine Products's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Natures Sunshine Products shares trade at around 21x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Natures Sunshine Products's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$34 million.
The EBITDA is a measure of a Natures Sunshine Products's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$375.2 million|
|Operating margin TTM||6.17%|
|Gross profit TTM||USD$268.3 million|
|Return on assets TTM||6.4%|
|Return on equity TTM||12.75%|
|Market capitalisation||USD$348.9 million|
TTM: trailing 12 months
There are currently 115,059 Natures Sunshine Products shares held short by investors – that's known as Natures Sunshine Products's "short interest". This figure is 0.8% up from 114,191 last month.
There are a few different ways that this level of interest in shorting Natures Sunshine Products shares can be evaluated.
Natures Sunshine Products's "short interest ratio" (SIR) is the quantity of Natures Sunshine Products shares currently shorted divided by the average quantity of Natures Sunshine Products shares traded daily (recently around 75201.960784314). Natures Sunshine Products's SIR currently stands at 1.53. In other words for every 100,000 Natures Sunshine Products shares traded daily on the market, roughly 1530 shares are currently held short.
However Natures Sunshine Products's short interest can also be evaluated against the total number of Natures Sunshine Products shares, or, against the total number of tradable Natures Sunshine Products shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Natures Sunshine Products's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Natures Sunshine Products shares in existence, roughly 10 shares are currently held short) or 0.0165% of the tradable shares (for every 100,000 tradable Natures Sunshine Products shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Natures Sunshine Products.
Find out more about how you can short Natures Sunshine Products stock.
We're not expecting Natures Sunshine Products to pay a dividend over the next 12 months.
Natures Sunshine Products's shares were split on 15 August 2013.
Over the last 12 months, Natures Sunshine Products's shares have ranged in value from as little as $5.5 up to $18.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Natures Sunshine Products's is 0.8501. This would suggest that Natures Sunshine Products's shares are less volatile than average (for this exchange).
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent managers and distributors. Nature's Sunshine Products, Inc. was founded in 1972 and is based in Lehi, Utah.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.